A new analysis released by the Kaiser Family Foundation?s Commission on Medicaid and the Uninsured provides an overview of online applications for Medicaid and/or Children's Health Insurance Program (CHIP).
A new analysis released by the Kaiser Family Foundation’s Commission on Medicaid and the Uninsured provides an overview of online applications for Medicaid and/or Children's Health Insurance Program(CHIP). It examines the extent to which they incorporate features that streamline and simplify the enrollment process for individuals.
Online applications can minimize burdens on individuals and help increase enrollment by making the application available around the clock, enabling faster or real-time eligibility determinations, and streamlining and simplifying the application process. States can also benefit from online applications through reduced administrative burdens and increased accuracy and efficiency. Thirty-two states currently offer an online application for Medicaid and/or CHIP that is accessible by the public and can be electronically submitted, but they vary in their capabilities and features.
Although states have made progress in developing online applications, there is still a substantial amount of work ahead to develop applications that will fulfill the functions and requirements outlined under Patient Protection and Affordable Care Act (PPACA). Under the PPACA, states are required to develop integrated and coordinated eligibility processes for Medicaid, CHIP and Exchange coverage that are supported by technology. As part of these processes, states will be required to provide a single application that individuals can use to apply for these programs that is available in multiple formats, including online.
The analysis was conducted with the Center on Budget and Policy Priorities.
Briana Contreras, an editor of Managed Healthcare Executive, spoke with Fred Turner, CEO of Curative, in this month’s episode about the challenges middle-class Americans face in dealing with medical debt, exploring the causes behind it and the impact on overall health.
Listen
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen